For instance, a favourable response to colchicine prophylaxis is a major diagnostic clue to the diagnosis of FMF [236], whereas constitutive activation of the IL-1 secreting platform is the backstory of CAPS, which dramatically responds to IL-1 antagonists [237]. This evidence concerns the gene IL1B and familial Mediterranean fever.